Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol Acetate in AIDS Patients With Anorexia and Cachexia
NCT00002300Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of megestrol in anorexia nervosa (AN) and cachexia (4 arms), sponsored by Bristol Myers Squibb. Primary endpoint: Body weight change at 12 weeks. Status: completed.
02
Drugs
megestrol
03
Conditions
anorexia nervosa (AN)cachexia
Beyond the preview
Go deeper on NCT00002300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002300.